4//SEC Filing
Zankel Todd 4
Accession 0001140361-12-038873
CIK 0001070698other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 9:46 PM ET
Size
8.7 KB
Accession
0001140361-12-038873
Insider Transaction Report
Form 4
Zankel Todd
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2012-08-27$2.02/sh+287$580→ 669,637 total - Sale
Common Stock
2012-08-27$5.00/sh−287$1,435→ 669,350 total - Exercise/Conversion
Stock options (right to buy)
2012-08-27+287→ 312,563 totalExercise: $2.02From: 2010-03-09Exp: 2020-03-08→ Common Stock (287 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- [F2]Original option grant vests 6/48ths on March 9, 2010 and 1/48th per month thereafter.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeother
Related Parties
1- filerCIK 0001362490
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 9:46 PM ET
- Size
- 8.7 KB